Orchid Discloses CEO Kelly s Severance; Jorge Leon Lands on CytoCore s Medical Advisory Board; Eksigent and Epidauros Tap New CEOs; Myriad s Scholl Moves to Genzyme; and Others | GenomeWeb

NEW YORK, May 1 (GenomeWeb News) - Orchid Cellmark on April 26 said it had entered into a severance agreement with Paul Kelly, whom Orchid fired March 8.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.